NEOPLASMA
Zoznam článkov
Volume 66, 2019, No. 3
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Obsah:
- Huang, S. - Wang, B. - Liao, Q. - Shen, C. - Li, W.: Pituitary tumor transforming gene binding factor (PBF) is required for androgen-induced prostate cancer proliferation and invasion. (s. 327)
- Mao, H. - Liu, S. - Kong, G. - Xu, Y. - Xu, Y. - Sun, G. - Wang, Z. - Han, F. - Tong, J. - Bo, P.: FBLN3 inhibited the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway. (s. 336)
- Wang, R. - Ye, X. - Zhao, X. - Liu, J. - Zhang, C.: Development of a five-gene signature as a novel prognostic marker in ovarian cancer. (s. 343)
- Li, G. - Cheng, Y. - Li, B. - Zhang, C. - Zhang, X. - Su, J. - Wang, C. - Chang, L. - Zhang, D. - Tan, C. - Wang, N.: miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a. (s. 350)
- Muller, A. - Gasch, J. - Albring, K. - Aberger, F. - Nivarthi, H. - Khemeri, M. - Moriggl, R. - Friedrich, K.: Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells. (s. 357)
- Zheng, G. - Song, K. - Zhao, Y.: Liver kinase B1 suppresses the metastasis and angiogenesis of lung cancer: involvement of the Shh signaling pathway. (s. 367)
- Sun, W. - Wang, L. - Luo, J. - Zhu, H. - Cai, Z.: Ambra1 inhibits paclitaxel-induced apoptosis in breast cancer cells by modulating the Bim/mitochondrial pathway. (s. 377)
- Chen, X. - Li, L. - Qiu, X. - Wu, H.: Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis. (s. 386)
- Li, W. - Xu, W. - Song, J. - Wu, T. - Wang, W.: LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma. (s. 397)
- Xu, X. - You, K. - Wu, B.: Zonula occludens-1 associated nucleic acid binding protein plays an invasion-promoting role in bladder cancer. (s. 405)
- Li, Y. - Lei, B. - Zou, J. - Wang, W. - Chen, A. - Zhang, J. - Fu, Y. - Li, Z.: High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer. (s. 420)
- Hao, T. - Li, C. - Ding, X. - Xing, X.: MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells. (s. 427)
- Lv, Z. - He, R. - Huang, M. - Zhao, G. - Ma, J. - Chen, G.: Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation. (s. 437)
- Tang, D. - Wu, Q. - Yuan, Z. - Xu, J. - Zhang, H. - Jin, Z. - Zhang, Q. - Xu, M. - Wang, Z. - Dai, Z. - Fang, H. - Li, Z. - Lin, C. - Shi, C. - Xu, M. - Sun, X. - Wang, D.: Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis. (s. 446)
- Wang, H. - Liu, D. - Yang, J.: Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method. (s. 459)
- Bai, Z. - Liu, Q. - Wang, X. - Liu, W.: APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis. (s. 470)
- Xiao, H. - Claret, F. - Shen, Q.: The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells. (s. 481)
- Liu, H. - Zhao, H.: Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma. (s. 487)
- Danihel jr., L. - Danihel sr., L. - Rajcok, M. - Mosna, K. - Belan, V. - Varga, I. - Schnorrer, M.: Significance of MRI in rectal carcinoma therapy optimization – correlation of preoperative T- and N-staging with definitive histopathological findings. (s. 494)
- Maisnar, V. - Stefanikova, Z. - Spicka, I. - Pour, L. - Minarik, J. - Flochova, E. - Radocha, J. - Gregora, E. - Stecova, N. - Jelinek, T. - Jungova, A. - Kralikova, E. - Brozova, L. - Hajek, R.: Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. (s. 499)